If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
For topical users , medical professionals have conveyed to us that GHK-Cu often yields results along the following timeline: First two weeks: Users may notice better skin hydration, reduced redness or irritation, and smoother skin
Why Safe Peptide Therapy Requires Medical Supervision and Baseline Bloodwork A responsible protocol begins with baseline bloodwork , explains Dr
10.1590/S0100-72032008000700008 73 WangZ.MengC
Some of the most commonly reported side effects (often connected to synthetic versions and high doses) include: Morning Grogginess Drowsiness Headache Nausea Dizziness Excess Fatigue Irritability Stomach Discomfort Mood Imbalance Typically, these side effects are felt in the morning